An observational study in Carotid Web, sponsored by University of Ostrava. Recruiting at 1 site in Czechia. Open to participants aged 15 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-27.
Sponsored by University of Ostrava · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A carotid web (CaW) is a shelf-like, thin, triangular endoluminal projection typically arising from the posterior wall of the internal carotid artery (ICA) bulb. CaW is considered by many to be an intimal variant of fibromuscular dysplasia and is associated with an increased risk of ischemic stroke in otherwise low-risk, younger patients. The CaWY study is a cross-sectional, multicenter, population-based sonographic survey with blinded central image adjudication, reported in accordance with STROBE guidelines for cross-sectional studies, aimed at estimating the prevalence of CaW detected by duplex sonography in the general population aged 15-25 years.
Objectives and Hypotheses Primary objective: Estimate the point prevalence of carotid web in a general young adult population aged 15-25 years using duplex sonography.
Secondary objectives:
Hypothesis: Carotid web is present in 2 % of the general 15-25-year population (two-sided). (This is a planning assumption; true prevalence may be lower/higher. Literature in symptomatic cohorts ranges roughly 2%, higher in cryptogenic stroke; general-population data are lacking.)
Study Population Setting \& sampling frame
Sample Size Assumptions
Ultrasound Acquisition Protocol Equipment \& presets
Scanning sequence (bilateral)
Image storage
Definite carotid web:
Inclusion criteria:
Exclusion criteria:
Suspected carotid web:
Inclusion criteria:
1. Focal echogenic lesion in the carotid bifurcation (15 mm proximally to the flow divider and 15 mm distally) 2. Minimal intraluminal prominence (width) 1.5 mm 3. One out of these criteria:
In transversal view: Transversal linear defect with echogenic surface projecting in the arterial lumen (the shape should be nest-like)
Exclusion criteria:
1. Presence of carotid plaque (Mannheim consensus) in the posterior wall
Differential sonographic features to record: typical plaque (echogenic/heterogeneous with surface calcification), carotid diaphragm, dissection flap (mobile, intramural hematoma), carotid web with superimposed thrombus.
7) Sonographic Case Definition of Carotid Web
Required equipment/settings (if specified in your criteria):
Diagnostic categories (tick all that apply):
Morphologic measurements (standardized):
Hemodynamic signatures (as per your thresholds):
Differential exclusion checklist (define image features to rule out):
Image acquisition minimums (per side):
Quality grading (apply your rules):
Reader guidance \& adjudication using your criteria:
Reliability: 10% random sample re-read for inter-observer agreement (Cohen's κ for categorical calls; ICC for continuous measures).
9) Data Collection
Imaging quality scores and reasons for non-diagnostic studies.
10) Validation Substudy
Participants with definite or possible CaW on DUS plus 1:2 matched DUS-negative controls (matched by age/sex/site) will be invited for CTA within 4 weeks to evaluate concordance (index test: DUS; reference standard: CTA with thin-slice oblique sagittal reconstructions). Outcome: sensitivity/specificity and positive predictive value of DUS criteria. (CTA descriptions of CaW as thin, shelf-like posterior bulb defects guide the reference call.)
11) Statistical Analysis Plan
Sensitivity analyses: (i) include possible CaW as positive; (ii) restrict to scans with top quality scores; (iii) per-reader estimates.
13) Bias Minimization \& Quality Control
Maintain blinding; lock image sets before adjudication.
14) Ethics and Safety
University of Ostrava is the lead sponsor of 10 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
General population aged 15 - 25 years
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Age 15 - 25 years
Prevalence
Prevalence of web in youth population
Time frame: on the day of the ultrasound examination
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Ostrava